LabCorp (LH) Outpaces Stock Market Gains: What You Should Know

LabCorp (LH) Outpaces Stock Market Gains: What You Should Know

0902 Q19%20Total%20Markets%20photos%20and%20gif CC8

LabCorp (LH) closed the most recent trading day at $177.41, moving +1.81% from the previous trading session. This change outpaced the S&P 500’s 0.67% gain on the day. Elsewhere, the Dow gained 0.57%, while the tech-heavy Nasdaq added 0.61%.

Prior to today’s trading, shares of the medical laboratory operator had lost 10.56% over the past month. This has lagged the Medical sector’s gain of 0.38% and the S&P 500’s gain of 7.78% in that time.

Investors will be hoping for strength from LH as it approaches its next earnings release. On that day, LH is projected to report earnings of $4.73 per share, which would represent year-over-year growth of 63.1%. Meanwhile, our latest consensus estimate is calling for revenue of $3.48 billion, up 18.99% from the prior-year quarter.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $13.84 per share and revenue of $12.69 billion. These totals would mark changes of +22.26% and +9.87%, respectively, from last year.

Any recent changes to analyst estimates for LH should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company’s business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 5.66% higher. LH currently has a Zacks Rank of #3 (Hold).

Investors should also note LH’s current valuation metrics, including its Forward P/E ratio of 12.59. Its industry sports an average Forward P/E of 37.03, so we one might conclude that LH is trading at a discount comparatively.

Investors should also note that LH has a PEG ratio of 1.46 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company’s expected earnings growth rate. LH’s industry had an average PEG ratio of 3.25 as of yesterday’s close.

The Medical – Dental Supplies industry is part of the Medical sector. This group has a Zacks Industry Rank of 78, putting it in the top 31% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Source: Nasdaq

Leave A Comment

Your email address will not be published. Required fields are marked *